Literature DB >> 10366512

Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.

D O Cicero1, G Barbato, U Koch, P Ingallinella, E Bianchi, M C Nardi, C Steinkühler, R Cortese, V Matassa, R De Francesco, A Pessi, R Bazzo.   

Abstract

The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products of natural substrates, with the protease of human hepatitis C virus (HCV) are characterized by NMR and modelling studies. The S-binding region of the enzyme and the bound conformation of the ligands are experimentally determined. The NMR data are then used as the experimental basis for modelling studies of the structure of the complex. The S-binding region involves the loop connecting strands E2 and F2, and appears shallow and solvent-exposed. The ligand binds in an extended conformation, forming an antiparallel beta-sheet with strand E2 of the protein, with the P1 carboxylate group in the oxyanion hole. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366512     DOI: 10.1006/jmbi.1999.2746

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.

Authors:  G Barbato; D O Cicero; F Cordier; F Narjes; B Gerlach; S Sambucini; S Grzesiek; V G Matassa; R De Francesco; R Bazzo
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

Authors:  T Ueno; S Misawa; Y Ohba; M Matsumoto; M Mizunuma; N Kasai; K Tsumoto; I Kumagai; H Hayashi
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.

Authors:  Annarita Casbarra; Fabrizio Dal Piaz; Paolo Ingallinella; Stefania Orrù; Piero Pucci; Antonello Pessi; Elisabetta Bianchi
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

Review 4.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

5.  Measurement of homonuclear three-bond J(H(N)Halpha) coupling constants in unlabeled peptides complexed with labeled proteins: application to a decapeptide inhibitor bound to the proteinase domain of the NS3 protein of hepatitis C virus (HCV).

Authors:  D O Cicero; G Barbato; U Koch; P Ingallinella; E Bianchi; S Sambucini; P Neddermann; R De Francesco; A Pessi; R Bazzo
Journal:  J Biomol NMR       Date:  2001-05       Impact factor: 2.835

6.  Using tert-Butyl Groups in a Ligand To Identify Its Binding Site on a Protein.

Authors:  Wan-Na Chen; Gottfried Otting
Journal:  ACS Med Chem Lett       Date:  2018-01-12       Impact factor: 4.345

7.  In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.

Authors:  Caterina Trozzi; Linda Bartholomew; Alessandra Ceccacci; Gabriella Biasiol; Laura Pacini; Sergio Altamura; Frank Narjes; Ester Muraglia; Giacomo Paonessa; Uwe Koch; Raffaele De Francesco; Christian Steinkuhler; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro.

Authors:  Liangjun Lu; Tami J Pilot-Matias; Kent D Stewart; John T Randolph; Ron Pithawalla; Wenping He; Peggy P Huang; Larry L Klein; Hongmei Mo; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple hepatitis C virus genotypes.

Authors:  Hyun Lee; Tian Zhu; Kavankumar Patel; Yan-Yan Zhang; Lena Truong; Kirk E Hevener; Joseph L Gatuz; Gitanjali Subramanya; Hyun-Young Jeong; Susan L Uprichard; Michael E Johnson
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

Review 10.  Viral protease inhibitors.

Authors:  Jeffrey Anderson; Celia Schiffer; Sook-Kyung Lee; Ronald Swanstrom
Journal:  Handb Exp Pharmacol       Date:  2009
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.